Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization and Evaluation of the Diagnosis and Treatment System for Diabetic Retinopathy in Type 2 Diabetes Mellitus

NCT06821399 is registered in ClinicalTrials.gov with Yufan Wang as lead sponsor.

NCT NCT06821399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06821399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization and Evaluation of the Diagnosis and Treatment System for Diabetic Retinopathy in Type 2 Diabetes Mellitus
Lead sponsor
Yufan Wang
Phase
Observational
Overall status
Recruiting
Start date
February 1, 2025
Completion date
July 31, 2028
Enrollment
2,920 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetic retinopathy, type 2 diabetes mellitus (t2dm)